| View |
|
DRP-14782
|
Carboplatin
|
Apocartin-150
|
150 mg/15 mL (10 mg/mL)
|
Solution for Intravenous
Infusion
|
-
|
Admac Lifesciences
|
India
|
Initial
|
04 January 2024
|
04 January 2029
|
| View |
|
DRP-14776
|
Norepinephrine (as bitartrate)
|
Norphrine 2
|
2 mg/mL (8 mg/4 mL)
|
Solution for Injection (I.V.
Infusion)
|
-
|
Ultra Laboratories Private Limited
|
India
|
Initial
|
03 January 2024
|
03 January 2029
|
| View |
|
DRP-14777
|
Norepinephrine (as bitartrate)
|
Norphrine 1
|
1 mg/mL (4 mg/4 mL)
|
Solution for Injection (I.V. Infusion)
|
-
|
Ultra Laboratories Private Limited
|
India
|
Initial
|
03 January 2024
|
03 January 2029
|
| View |
|
DRP-14779
|
Olopatadine (as hydrochloride)
|
Opadinex
|
1 mg/mL (0.1% w/v)
|
Sterile Ophthalmic Solution (Drops)
|
-
|
Beximco Pharmaceuticals Ltd.
|
Bangladesh
|
Initial
|
03 January 2024
|
03 January 2029
|
| View |
|
DRP-14784
|
Carboplatin
|
None
|
150 mg/15 mL (10 mg/mL)
|
Solution for Intravenous
Infusion
|
-
|
Venus Remedies Limited.
|
India
|
Initial
|
04 January 2024
|
04 January 2029
|
| View |
|
DRP-14783
|
Carboplatin
|
None
|
450 mg/45 mL (10 mg/mL)
|
Solution for Intravenous
Infusion
|
-
|
Venus Remedies Limited
|
India
|
Initial
|
04 January 2024
|
04 January 2029
|
| View |
|
DRP-14785
|
Carboplatin
|
None
|
150 mg/15 mL (10 mg/mL) and 450 mg/mL (10 mg/mL)
|
Solution for Intravenous Infusion
|
-
|
Hetero Labs Limited (Unit VI)
|
India
|
Initial
|
04 January 2024
|
04 January 2029
|
| View |
|
DR-XY48971
|
Phytomenadione
|
Hema-K
|
10 mg/mL
|
Solution for Injection (I.M./I.V.)
|
-
|
Ciron Drugs & Pharmaceuticals Pvt. Ltd.
|
India
|
Initial
|
03 January 2024
|
03 January 2029
|
| View |
|
DR-XY48972
|
Ivabradine (as hydrochloride)
|
Garda
|
7.5 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
04 January 2024
|
04 January 2029
|
| View |
|
DR-XY48973
|
Ivabradine (as hydrochloride)
|
Garda
|
5 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
04 January 2024
|
04 January 2029
|
| View |
|
DRP-14788
|
Tadalafil
|
Robust-T
|
5 mg
|
Film-Coated Tablet
|
-
|
Phil. United Pharma Corporation
|
Philippines
|
Initial
|
04 January 2024
|
04 January 2029
|
| View |
|
DRP-14786
|
Tadalafil
|
None
|
5 mg
|
Film-Coated Tablet
|
-
|
Phil. United Pharma Corporation
|
Philippines
|
Initial
|
04 January 2024
|
04 January 2029
|
| View |
|
DRP-14787
|
Tadalafil
|
DocFil
|
5 mg
|
Film-Coated Tablet
|
-
|
PHIL. UNITED PHARMA CORPORATION
|
Philippines
|
Initial
|
04 January 2024
|
04 January 2029
|
| View |
|
DRHR-2323
|
Isopropyl Alcohol
|
None
|
750 mL per 100 mL (70% v/v)
|
Topical Solution.
(with moisturizer powder scent)
|
-
|
J. Chemie Laboratories, Inc.
|
Philippines
|
Initial
|
04 January 2024
|
04 January 2027
|
| View |
|
DRP-14789
|
Co-Amoxiclav
|
None
|
457mg/5mL
|
Powder For Suspension
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
05 January 2024
|
05 January 2029
|
| View |
|
DRP-14790
|
Co-Amoxiclav
|
Lactamox
|
457mg/5mL
|
Powder For Suspension
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
05 January 2024
|
05 January 2029
|
| View |
|
DRP-14659
|
Meclizine hydrochloride
|
None
|
12.5 mg
|
Chewable Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc,
|
Philippines
|
Initial [OTC]
|
05 January 2024
|
17 November 2028
|
| View |
|
DRP-14798
|
0.9% Sodium Chloride
|
Nacsol
|
900 mg/100 mL (0.9% w/v)
|
Solution For Intravenous Infusion
|
-
|
SHIJIAZHUANG NO. 4 PHARMACEUTICAL CO., LTD.
|
China
|
Initial
|
09 January 2024
|
09 January 2029
|
| View |
|
DRP-14797
|
Guaifenesin + Salbutamol (as sulfate)
|
Peesaph-G
|
50 mg/1 mg per 5 mL
|
Syrup
|
-
|
Azine Healthcare Pvt. Ltd.
|
India
|
Initial
|
09 January 2024
|
09 January 2029
|
| View |
|
DRP-14796
|
Guaifenesin + Bromhexine Hydrochloride + Salbutamol (as sulfate)
|
Coughsaph-1
|
50 mg/4 mg/ 1 mg per 5 mL
|
Syrup
|
-
|
Azine Healthcare Pvt. Ltd.
|
India
|
Initial
|
09 January 2024
|
09 January 2029
|